Clinical Trials Directory

Trials / Completed

CompletedNCT00944723

Impact of Mass Zinc Fortification Programs on Plasma Zinc Concentration

Evaluation of the Use of Plasma Zinc Concentration for Assessing the Impact of Targeted and Mass Zinc Fortification Programs

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
132 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of the study is to evaluate the use of plasma zinc concentration for assessing the impact of mass zinc fortification programs.

Detailed description

The objectives of the present study are to determine whether plasma zinc concentration changes in response to additional zinc consumption, as provided by zinc-fortified cereal-based complementary foods fed to adult men (fortified at a level consistent with currently proposed levels). The following specific steps will be completed: 1. Zinc-fortified breads prepared from zinc-fortified wheat flour will be developed with assistance from experts in food technology. 2. A four-week feeding trial will be implemented to assess the change in plasma zinc concentration among young adult men who receive: a) bread fortified with a moderate amount of zinc and a liquid vitamin preparation between meals; b) bread fortified with a large amount zinc and a liquid vitamin preparation between meals; c) non-zinc-fortified bread and a liquid vitamin preparation between meals \[negative control group\]; and d) non-zinc-fortified bread and a zinc-containing liquid vitamin preparation between meals \[positive control group\].

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTZinc-fortified breadBread made with zinc-fortified wheat flour
DIETARY_SUPPLEMENTZinc supplementLiquid supplement with zinc
DIETARY_SUPPLEMENTNon-fortified breadDaily consumption of non-fortified bread
DIETARY_SUPPLEMENTPlacebo supplementDaily intake of placebo supplement

Timeline

Start date
2009-08-01
Primary completion
2010-01-01
Completion
2010-02-01
First posted
2009-07-23
Last updated
2010-02-19

Locations

1 site across 1 country: Senegal

Source: ClinicalTrials.gov record NCT00944723. Inclusion in this directory is not an endorsement.